Select Page
Responsive Centered YouTube Video
Analysis of ongoing pandemic situation, concerns about new variant ba2.86 evading antibodies.
  • Pandemic declared over but still having high cases worldwide. 0:15

  • Lack of adequate research including histopathology with autopsy analysis. 0:24

  • Discussion on neutralization escape by sarov 2 Omicron subvariant ba2.86. 1:00

  • Concerns about new variant evading neutralizing antibodies induced by vaccination or infection. 3:11

Analysis of global COVID-19 variants and vaccine impact on antibodies.
  • Global transition of COVID-19 variants from April to September 2023. 4:08

  • EG5.1 variant expanding significantly worldwide. 4:52

  • Emerging variants commonly sampled in China, Australia, and Sweden. 5:36

  • Ba286 variant surging in South Africa. 5:56

  • Impact of Ba286 variant on antibodies studied with bivalent booster. 6:41

  • Comparison of antibody response with and without bivalent booster. 7:04

  • Analysis of original variant and Ba286 variant antibody response. 7:24

Analysis of antibody response to different virus variants and the impact of infection on antibody levels.
  • Antibody response to original virus stronger than variants after booster shot. 8:03

  • Immune imprinting observed where primary response is still to original virus. 8:39

  • Significant increase in antibody levels after infection compared to no infection. 8:58

  • IGG4 levels showed a 38 times increase post third dose of vaccines. 10:07

  • Different categories of IG breakdown with IG1 and IG3 triggering immune response. 11:15

Concerns about immune system response, high circulation of virus in vaccinated regions, and rising cases and deaths in Finland.
  • IgG4 triggers tolerance in the immune system 11:34

  • High IgG4 levels may lead to immune system not responding effectively to infections 11:50

  • High vaccination levels may contribute to high virus circulation in certain regions 12:07

  • Importance of understanding immune mechanisms to address mild infections seriously 12:25

  • Concerns about rising cases and deaths within 30 days in Finland 13:26

  • Significant increase in cases and deaths as winter approaches 14:02

  • Need to investigate interaction with IgG4 to understand pandemic phase 14:57

Uncovering potential causes of mortality beyond severe COVID-19, highlighting concerns about immune response and the need for further investigation.
  • mRNA plays a significant role in the immune response, particularly in the absence of infection or adenovirus vaccines. 15:07

  • Presence of IgG4 in immune response raises questions about its implications during infection and immune storms. 15:51

  • Concerns about mild or asymptomatic infections triggering immune storms leading to severe disease and death within three months. 16:25

  • Emphasizing the importance of understanding immune responses through autopsies for effective mitigation strategies. 17:03

  • Anticipating a challenging winter in the Northern Hemisphere due to rising numbers and potential impacts of immune responses. 17:30

  • Highlighting the critical need for answers to address the evolving situation and potential solutions for mitigation. 17:37